CD274 and cancer: Moreover, it appears that modest generation of ROS by cancer cells can trigger hypoxia [63], which can modulate immunity by regulating the expression of co-stimulatory (CD137, OX-40) and co-inhibitory (PD-L1) molecules for T and NK cell activation [64].